Standard Biotools Inc Cash Flow-to-Debt Ratio
Standard Biotools Inc cash flow-to-debt ratio. Standard Biotools Inc (LAB) has a Cash Flow-to-Debt Ratio of -0.12x as of June 2026, meaning its operating cash flow of $-10.31 Million could theoretically repay 0% of its total liabilities ($87.25 Million) in one year. Check LAB cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Standard Biotools Inc (2006–2025)
Cash flow-to-debt ratio of Standard Biotools Inc from 2006 to 2025. Historical debt coverage capacity for Standard Biotools Inc across 20 annual periods. Check LAB capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Standard Biotools Inc Cash Flow-to-Debt Ratio by Year (2006–2025)
Standard Biotools Inc cash flow-to-debt ratio by year from 2006 to 2025. Year-by-year debt coverage analysis for Standard Biotools Inc. For the full cash flow conversion analysis, see cash flow conversion of Standard Biotools Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | $-74.35 Million | $143.46 Million | ▲ +49.2% |
| 2024 | -1.02x | $-143.45 Million | $140.62 Million | ▼ -1010.3% |
| 2023 | -0.09x | $-43.29 Million | $471.12 Million | ▲ +51.5% |
| 2022 | -0.19x | $-89.37 Million | $471.78 Million | ▲ +22.3% |
| 2021 | -0.24x | $-44.06 Million | $180.62 Million | ▼ -193.8% |
| 2020 | -0.08x | $-15.42 Million | $185.71 Million | ▲ +73.8% |
| 2019 | -0.32x | $-35.21 Million | $111.20 Million | ▼ -190.9% |
| 2018 | -0.11x | $-25.20 Million | $231.53 Million | ▼ -15.8% |
| 2017 | -0.09x | $-24.10 Million | $256.42 Million | ▲ +39.1% |
| 2016 | -0.15x | $-39.10 Million | $253.16 Million | ▼ -14.0% |
| 2015 | -0.14x | $-34.70 Million | $256.16 Million | ▼ -54.0% |
| 2014 | -0.09x | $-22.62 Million | $257.14 Million | ▼ -9.5% |
| 2013 | -0.08x | $-1.59 Million | $19.80 Million | ▲ +94.0% |
| 2012 | -1.34x | $-17.48 Million | $13.07 Million | ▼ -70.9% |
| 2011 | -0.78x | $-17.54 Million | $22.43 Million | ▼ -1354.2% |
| 2010 | -0.05x | $-11.51 Million | $213.97 Million | ▲ +43.3% |
| 2009 | -0.09x | $-19.51 Million | $205.77 Million | ▲ +37.0% |
| 2008 | -0.15x | $-28.72 Million | $190.69 Million | ▼ -28.1% |
| 2007 | -0.12x | $-21.76 Million | $185.11 Million | ▲ +24.8% |
| 2006 | -0.16x | $-22.31 Million | $142.66 Million | — |